These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 2034293)

  • 1. Validatable virus removal from protein solutions.
    DiLeo AJ; Allegrezza AE
    Nature; 1991 May; 351(6325):420-1. PubMed ID: 2034293
    [No Abstract]   [Full Text] [Related]  

  • 2. Implementation of a 20-nm pore-size filter in the plasma-derived factor VIII manufacturing process.
    Furuya K; Murai K; Yokoyama T; Maeno H; Takeda Y; Murozuka T; Wakisaka A; Tanifuji M; Tomono T
    Vox Sang; 2006 Aug; 91(2):119-25. PubMed ID: 16907872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Size exclusion removal of model mammalian viruses using a unique membrane system, Part I: Membrane qualification.
    DiLeo AJ; Vacante DA; Deane EF
    Biologicals; 1993 Sep; 21(3):275-86. PubMed ID: 8117441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combined membrane and alginate filtration for virus concentration in water].
    Schierbaum L
    Zentralbl Bakteriol Orig; 1968; 207(4):453-6. PubMed ID: 5742978
    [No Abstract]   [Full Text] [Related]  

  • 5. Removal of small non-enveloped viruses by nanofiltration.
    Yokoyama T; Murai K; Murozuka T; Wakisaka A; Tanifuji M; Fujii N; Tomono T
    Vox Sang; 2004 May; 86(4):225-9. PubMed ID: 15144526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Removal of virus through novel membrane filtration method.
    Manabe S
    Dev Biol Stand; 1996; 88():81-90. PubMed ID: 9119166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A validatable membrane-based system for the removal of viruses from biopharmaceuticals.
    Sekhri PJ; Levy RV
    Am Biotechnol Lab; 1992 Feb; 10(1):53. PubMed ID: 1367874
    [No Abstract]   [Full Text] [Related]  

  • 8. Size exclusion removal of model mammalian viruses using a unique membrane system, Part II: Module qualification and process simulation.
    DiLeo AJ; Vacante DA; Deane EF
    Biologicals; 1993 Sep; 21(3):287-96. PubMed ID: 8117442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of solution pH on protein transmission and membrane capacity during virus filtration.
    Bakhshayeshi M; Zydney AL
    Biotechnol Bioeng; 2008 May; 100(1):108-17. PubMed ID: 18080342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of bacteriophages as surrogates for mammalian viruses.
    McAlister M; Aranha H; Larson R
    Dev Biol (Basel); 2004; 118():89-98. PubMed ID: 15645677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanoceramics for blood-borne virus removal.
    Zhao Y; Sugiyama S; Miller T; Miao X
    Expert Rev Med Devices; 2008 May; 5(3):395-405. PubMed ID: 18452389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Removal of small nonenveloped viruses by antibody-enhanced nanofiltration during the manufacture of plasma derivatives.
    Kreil TR; Wieser A; Berting A; Spruth M; Medek C; Pölsler G; Gaida T; Hämmerle T; Teschner W; Schwarz HP; Barrett PN
    Transfusion; 2006 Jul; 46(7):1143-51. PubMed ID: 16836561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein purification process engineeering. Crossflow membrane filtration.
    Su ZG; Colton CK
    Bioprocess Technol; 1994; 18():57-85. PubMed ID: 7764175
    [No Abstract]   [Full Text] [Related]  

  • 14. Virus filtration of high-concentration monoclonal antibody solutions.
    Marques BF; Roush DJ; Göklen KE
    Biotechnol Prog; 2009; 25(2):483-91. PubMed ID: 19353736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PDA Virus Filter Task Force update.
    Sofer G
    Dev Biol (Basel); 2004; 118():129-31. PubMed ID: 15645682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The removal of viruses during the purification of equine antisera using filtration aids Hyflo Super-Cel and Fulmon Super A.
    Cameron-Smith R; Miloradovic L; Cheyne I; Healy K
    Biologicals; 2000 Sep; 28(3):169-74. PubMed ID: 10964443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of a MFM 0142 membrane viral concentration module during sanitary and virological surveillance of water objects].
    Sanamian AG; Dmitrieva RA; Doskina TV; Lavrova DV; Nedachin AE
    Gig Sanit; 2006; (6):74-6. PubMed ID: 17190069
    [No Abstract]   [Full Text] [Related]  

  • 18. Elimination of viruses, bacteria and protozoan oocysts by slow sand filtration.
    Hijnen WA; Schijven JF; Bonné P; Visser A; Medema GJ
    Water Sci Technol; 2004; 50(1):147-54. PubMed ID: 15318501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement of virus safety of an antihemophilc factor IX by virus filtration process.
    Kim IS; Choi YW; Kang Y; Sung HM; Sohn KW; Kim YS
    J Microbiol Biotechnol; 2008 Jul; 18(7):1317-25. PubMed ID: 18667862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus removal by unsaturated wastewater filtration: effects of biofilm accumulation and hydrophobicity.
    Heistad A; Scott T; Skaarer AM; Seidu R; Hanssen JF; Stenström TA
    Water Sci Technol; 2009; 60(2):399-407. PubMed ID: 19633382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.